Reprint: Good laboratory practice: preventing introduction of bias at the bench - PubMed (original) (raw)
Review
doi: 10.1038/jcbfm.2008.101. Epub 2008 Sep 17.
Marc Fisher, Victoria O'Collins, Emily S Sena, Ulrich Dirnagl, Philip M W Bath, Alastair Buchan, H Bart van der Worp, Richard J Traystman, Kazuo Minematsu, Geoffrey A Donnan, David W Howells
Affiliations
- PMID: 18797473
- PMCID: PMC2729492
- DOI: 10.1038/jcbfm.2008.101
Review
Reprint: Good laboratory practice: preventing introduction of bias at the bench
Malcolm R Macleod et al. J Cereb Blood Flow Metab. 2009 Feb.
Erratum in
- J Cereb Blood Flow Metab. 2009 Jun;29(6):1226. Buchan, Alistair [corrected to Buchan, Alastair]
Abstract
As a research community, we have failed to show that drugs, which show substantial efficacy in animal models of cerebral ischemia, can also improve outcome in human stroke. Accumulating evidence suggests this may be due, at least in part, to problems in the design, conduct, and reporting of animal experiments which create a systematic bias resulting in the overstatement of neuroprotective efficacy. Here, we set out a series of measures to reduce bias in the design, conduct and reporting of animal experiments modeling human stroke.
Similar articles
- Reprint: Good laboratory practice: preventing introduction of bias at the bench.
Macleod MR, Fisher M, O'Collins V, Sena ES, Dirnagl U, Bath PM, Buchan A, van der Worp HB, Traystman RJ, Minematsu K, Donnan GA, Howells DW. Macleod MR, et al. Int J Stroke. 2009 Feb;4(1):3-5. doi: 10.1111/j.1747-4949.2009.00241.x. Int J Stroke. 2009. PMID: 19236488 - Good laboratory practice: preventing introduction of bias at the bench.
Macleod MR, Fisher M, O'Collins V, Sena ES, Dirnagl U, Bath PM, Buchan A, van der Worp HB, Traystman R, Minematsu K, Donnan GA, Howells DW. Macleod MR, et al. Stroke. 2009 Mar;40(3):e50-2. doi: 10.1161/STROKEAHA.108.525386. Epub 2008 Aug 14. Stroke. 2009. PMID: 18703798 - Evidence for the efficacy of NXY-059 in experimental focal cerebral ischaemia is confounded by study quality.
Macleod MR, van der Worp HB, Sena ES, Howells DW, Dirnagl U, Donnan GA. Macleod MR, et al. Stroke. 2008 Oct;39(10):2824-9. doi: 10.1161/STROKEAHA.108.515957. Epub 2008 Jul 17. Stroke. 2008. PMID: 18635842 - Bench to bedside: the quest for quality in experimental stroke research.
Dirnagl U. Dirnagl U. J Cereb Blood Flow Metab. 2006 Dec;26(12):1465-78. doi: 10.1038/sj.jcbfm.9600298. Epub 2006 Mar 8. J Cereb Blood Flow Metab. 2006. PMID: 16525413 Review. - [In vivo exploration of cerebral ischemia: use of neuroprotective agents in animal studies].
Lestage P, Lockhart B, Roger A. Lestage P, et al. Therapie. 2002 Nov-Dec;57(6):554-63. Therapie. 2002. PMID: 12666263 Review. French.
Cited by
- Short-term effect of acute and repeated urinary bladder inflammation on thigmotactic behaviour in the laboratory rat.
Morland RH, Novejarque A, Huang W, Wodarski R, Denk F, Dawes JD, Pheby T, McMahon SB, Rice AS. Morland RH, et al. F1000Res. 2015 May 8;4:109. doi: 10.12688/f1000research.6255.1. eCollection 2015. F1000Res. 2015. PMID: 27158443 Free PMC article. - Stroke research at a road block: the streets from adversity should be paved with meta-analysis and good laboratory practice.
Dirnagl U, Macleod MR. Dirnagl U, et al. Br J Pharmacol. 2009 Aug;157(7):1154-6. doi: 10.1111/j.1476-5381.2009.00211.x. Epub 2009 Jun 23. Br J Pharmacol. 2009. PMID: 19664136 Free PMC article. - CARbon DIoxide for the treatment of Febrile seizures: rationale, feasibility, and design of the CARDIF-study.
Ohlraun S, Wollersheim T, Weiß C, Martus P, Weber-Carstens S, Schmitz D, Schuelke M. Ohlraun S, et al. J Transl Med. 2013 Jun 27;11:157. doi: 10.1186/1479-5876-11-157. J Transl Med. 2013. PMID: 23806032 Free PMC article. Clinical Trial. - RODENT STROKE MODEL GUIDELINES FOR PRECLINICAL STROKE TRIALS (1ST EDITION).
Liu S, Zhen G, Meloni BP, Campbell K, Winn HR. Liu S, et al. J Exp Stroke Transl Med. 2009 Jan 1;2(2):2-27. doi: 10.6030/1939-067x-2.2.2. J Exp Stroke Transl Med. 2009. PMID: 20369026 Free PMC article. - Magnetic resonance imaging in multiple sclerosis animal models: A systematic review, meta-analysis, and white paper.
Ineichen BV, Sati P, Granberg T, Absinta M, Lee NJ, Lefeuvre JA, Reich DS. Ineichen BV, et al. Neuroimage Clin. 2020;28:102371. doi: 10.1016/j.nicl.2020.102371. Epub 2020 Aug 2. Neuroimage Clin. 2020. PMID: 32818883 Free PMC article.
References
- Altman DG, Schulz KF, Moher D, Egger M, Davidoff F, Elbourne D, Gotzsche PC, Lang T. The revised consort statement for reporting randomized trials: Explanation and elaboration. Ann Intern Med. 2001;134:663–694. - PubMed
- Bath FJ, Owen VE, Bath PM. Quality of full and final publications reporting acute stroke trials: A systematic review. Stroke. 1998;29:2203–2210. - PubMed
- Begg C, Cho M, Eastwood S, Horton R, Moher D, Olkin I, Pitkin R, Rennie D, Schulz KF, Simel D, Stroup DF. Improving the quality of reporting of randomized controlled trials. The consort statement. JAMA. 1996;276:637–639. - PubMed
- Crossley NA, Sena E, Goehler J, Horn J, van der Worp B, Bath PM, Macleod M, Dirnagl U. Empirical evidence of bias in the design of experimental stroke studies: a metaepidemiologic approach. Stroke. 2008;39:929–934. - PubMed
- Dirnagl U. Bench to bedside: the quest for quality in experimental stroke research. J Cereb Blood Flow Metab. 2006;26:1465–1478. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Research Materials